-DOCSTART-	
	
Tauopathies	B-Process
represent	O
a	B-Process
group	I-Process
of	I-Process
neurodegenerative	I-Process
disorders	I-Process
characterized	O
by	O
the	B-Process
accumulation	I-Process
of	O
pathological	B-Material
TAU	I-Material
protein	I-Material
in	O
brains	B-Material
.	O
	
We	O
report	O
a	B-Material
human	I-Material
neuronal	I-Material
model	I-Material
of	O
tauopathy	B-Process
derived	B-Process
from	O
induced	B-Material
pluripotent	I-Material
stem	I-Material
cells	I-Material
(	I-Material
iPSCs	I-Material
)	I-Material
carrying	O
a	B-Process
TAU	I-Process
-	I-Process
A152	I-Process
T	I-Process
mutation	I-Process
.	O
	
Using	O
zinc	B-Process
-	I-Process
finger	I-Process
nuclease	I-Process
-	I-Process
mediated	I-Process
gene	I-Process
editing	I-Process
,	O
we	O
generated	B-Process
two	B-Material
isogenic	I-Material
iPSC	I-Material
lines	I-Material
:	O
one	O
with	O
the	B-Process
mutation	I-Process
corrected	B-Process
,	O
and	O
another	O
with	O
the	B-Process
homozygous	I-Process
mutation	I-Process
engineered	B-Process
.	O
	
The	B-Process
A152	I-Process
T	I-Process
mutation	I-Process
increased	B-Process
TAU	B-Process
fragmentation	I-Process
and	I-Process
phosphorylation	I-Process
,	O
leading	O
to	O
neurodegeneration	B-Process
and	O
especially	O
axonal	B-Process
degeneration	I-Process
.	O
	
These	B-Data
cellular	I-Data
phenotypes	I-Data
were	O
consistent	O
with	O
those	O
observed	O
in	O
a	B-Material
patient	I-Material
with	O
	
TAU	B-Material
-	I-Material
A152T.	I-Material
Upon	O
mutation	B-Process
correction	I-Process
,	O
normal	B-Data
neuronal	I-Data
and	I-Data
axonal	I-Data
morphologies	I-Data
were	O
restored	B-Process
,	O
accompanied	O
by	O
decreases	B-Process
in	O
TAU	B-Process
fragmentation	I-Process
and	I-Process
phosphorylation	I-Process
,	O
whereas	O
the	B-Data
severity	I-Data
of	O
tauopathy	B-Process
was	O
intensified	B-Process
in	O
neurons	B-Material
with	O
the	B-Process
homozygous	I-Process
mutation	I-Process
.	O
	
These	B-Material
isogenic	I-Material
TAU	I-Material
-	I-Material
iPSC	I-Material
lines	I-Material
represent	O
a	O
critical	O
advancement	O
toward	O
the	B-Process
accurate	I-Process
modeling	I-Process
and	O
mechanistic	B-Process
study	I-Process
of	O
tauopathies	B-Process
with	O
human	B-Material
neurons	I-Material
and	O
will	O
be	O
invaluable	O
for	O
drug	B-Process
-	I-Process
screening	I-Process
efforts	I-Process
and	O
future	O
cell	B-Process
-	I-Process
based	I-Process
therapies	I-Process
.	O
	
Highlights	O
•	O
	
A	B-Material
human	I-Material
neuron	I-Material
model	I-Material
of	O
tauopathy	B-Process
using	O
TAU	B-Material
-	I-Material
A152T	I-Material
-	I-Material
iPSCs	I-Material
•	O
Correction	B-Process
of	O
TAU	B-Process
-	I-Process
A152	I-Process
T	I-Process
mutation	I-Process
eliminates	B-Process
tauopathy	B-Process
•	O
Engineered	B-Process
homozygous	B-Process
TAU	I-Process
-	I-Process
A152	I-Process
T	I-Process
mutation	I-Process
intensifies	B-Process
tauopathy	B-Process
•	O
A152	B-Process
T	I-Process
mutation	I-Process
increases	B-Process
TAU	B-Process
proteolysis	I-Process
,	O
leading	O
to	O
tauopathy	B-Process
	
